Journal of IMAB - Annual Proceeding (Scientific Papers)
Publisher: Peytchinski, Gospodin Iliev
ISSN: 1312 773X (Online)
Issue: 2013, vol. 19, book 4
Subject Collection: Oral and Dental Medicine
Pages: 355-358
DOI: 10.5272/jimab.2013194.355
Published online: 08 August 2013

J of IMAB 2013; 19(4):355-358
Assya Krasteva 1Corresponding Autor, Vladimir E. Panov2, Dejan Jelev3, Krasimir Antonov3, Aneta Ivanova3, Zahariy Krastev3.
1) Department of Oral Imaging and Oral Diagnostic, Faculty of Dental Medicine, Medical University Sofia, Bulgaria
2) Faculty of Dental Medicine, Medical University Varna, Bulgaria
3) Clinic of Gastroenterology, University Hospital "St.Ivan Rilski", Medical University Sofia, Bulgaria.

Hepatitis B virus is the most important infectious hazard in dental profession. Vectors of HBV infection are not only blood, but also saliva, nasopharyngeal secretions, crevicular fluid.
The aim of the study was to evaluate serum and salivary HBV DNA levels in subjects with chronic infection and dynamics of HBV levels during the first 3 months of peginterferon α-2a therapy to be determined.
Nineteen parallel samples were tested for HBV DNA by real-time PCR assay.
All nineteen sera were positive for HBV DNA with levels ranging from 494 to 6 300 000 000 cp/ml. HBV DNA was detected in all saliva samples even in patients with very low viremia. HBV DNA levels in serum and saliva were quite similar in cases with serum HBV DNA < 10 000 cp/ml. Patients with viremia higher than 10 000 cp/ml had significantly lower HBV DNA levels in saliva.
The presence of HBV DNA in saliva might not be only due to transudation or exudation of fluid containing virus from the general circulation into various body fluids. These facts clearly demonstrate the role of saliva in routes of HBV transmission. Our results confirm the possibility of dentist’s particiation in infection transmission and suggests that salivary analysis holds promise as a non-invasive approach to identify biomarkers for diseases.

Key words: HBV DNA, saliva, peginterferon.

- Download FULL TEXT /PDF 598 KB/
Please cite this article as:
Krasteva A, Panov VE, Jelev D, Antonov K, Ivanova A, Krastev Z. Evaluation of HBV DNA levels in saliva in subjects with different viremia as well as during peginterferon α-2a therapy. J of IMAB. 2013; 19(4):355-358. doi: 10.5272/jimab.2013194.355.

Correspondence to: Dr. Assya Krasteva, Department of Oral Imaging and Oral Diagnostic, Faculty of Dental Medicine, Medical University Sofia; 1, St George Sofiisky str., 1431 Sofia, Bulgaria;

1. Harpaz R, Von Seidlein L, Averhoff F, Tormey MP, Sinha SD, Kotsopoulou K, et al. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med. 1996 Feb 29;334(9):549-54. [PubMed] [CrossRef]
2. Krasteva A, Panov VE, Garova M, Velicova R, Kisselova A, Krastev Z.  Hepatitis B and C in dentistry. J of IMAB. 2008; 14(2):38-40. [CrossRef]
3. Mori M. Status of viral hepatitis in the world community: its incidence among dentists and other dental personnel. Int Dent J. 1984 Jun;34(2):115-21. [PubMed]
4. Itharatana K. Viral hepatitis B infection. Transmission and prevention for dentists. [Article in Thai] J Dent Assoc Thai. 1988 Jul-Aug;38(4):180-7. [PubMed]
5. Karayiannis P, Novick DM, Lok AS, Fowler MJ, Monjardino J, Thomas HC. Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen. Br Med J (Clin Res Ed). 1985 Jun 22;290(6485):1853-5. [PubMed]
6. Noppornpanth S, Sathirapongsasuti N, Chongsrisawat V, Poovorawan Y. Detection of HbsAg and HBV DNA in serum and saliva of HBV carriers. Southeast Asian J Trop Med Public Health. 2000 Jun;31(2):419-21. [PubMed]
7. Kidd-Ljunggren K, Holmberg A, Blackberg J, Lindqvist B. High levels of hepatitis B virus DNA in body fluids from chronic carriers. J Hosp Infect. 2006 Dec;64(4):352-7. [PubMed] [CrossRef]
8. Jenison SA, Lemon SM, Baker LN, Newbold JE. Quantitative analysis of hepatitis B virus DNA in saliva and semen of chronic infected homosesexual men. J Infect Dis. 1987 Aug;156(2):299–307. [PubMed] [CrossRef]
9. Van der Eijk AA, Niesters HG, Hansen BE, Pas SD, Richardus JH, Mostert M, et al. Paired, quantitative measurements of hepatitis B virus DNA in saliva, urine and serum of chronic hepatitis B patients. Eur J Gastroenterol Hepatol. 2005 Nov;17(11):1173-9. [PubMed]
10. Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol. 2003; 39 Suppl 1:S64-9. [PubMed]
11. Bancroft WH, Snitbhan R, Scott RM, Tingpalapong M, Watson WT, Tanticharoenyos P, et al. Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. J Infect Dis. 1977 Jan;135(1):79-85. [PubMed] [CrossRef]
12. Alter HJ, Purcell RH, Gerin JL, London WT, Kaplan PM, McAuliffe VJ, et al. Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen. Infect Immun. 1977 Jun;16(3):928-33. [PubMed]
13. Dawes C, Weatherell JA. Kinetics of fluoride in the oral fluids. J Dent Res. 1990 Feb;69 Spec No:638-44. [PubMed]
14. Chen L, Liu F, Fan X, Gao J, Chen N, Wong T, et al. Detection of hepatitis B surface antigen, hepatitis B core antigen, and hepatitis B virus DNA in parotid tissues. Int J Infec Dis. 2009 Jan;13(1):20-3. [PubMed] [CrossRef]
15. Hui AY, Hung LC, Tse PC, Leung WK, Chan PK, Chan HL. Transmission of hepatitis B by human bite - confirmation by detection of virus in saliva and full genome sequencing. J Clin Virol. 2005 Jul;33(3):254-6. [PubMed] [CrossRef].

Received: 24 April 2013
Published online: 08 August 2013

back to Online Journal